Delivery Order SPE2DB24D2205-SPE2DB25FDXUH

Award Date 2/3/25
Potential Completion Date 2/25/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,242.40, is for the delivery of 4,566 units of XEOMIN 100 unit vials. This is a firm fixed-price delivery order contract with a completion date of November 15, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,118.20, is a Firm Fixed Price Delivery Order for the supply of XEOMIN 50 unit vials. The contract has an ultimate completion date of February 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $91,116.48 firm fixed-price delivery order is for the supply of 4,566,559,471 units of XEOMIN 200 UNIT VIALS. The contract has an ultimate completion date of December 18, 2024 and was awarded on November 26, 2024. This contract is not designated with a set-aside requirement, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,348.34 firm fixed-price delivery order is for the supply of XEOMIN 200 unit vials, a pharmaceutical product. The contract has an ultimate completion date of February 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,425.00 Firm Fixed Price Delivery Order is for the supply of XEOMIN 50 unit vials, with a completion date of November 25, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,559.10 firm fixed-price delivery order is for XEOMIN 50 UNIT VIALS, with a completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,583.68 firm fixed-price delivery order is for the supply of XEOMIN 100 unit vials, with a period of performance through December 10, 2024. The contract does not have a set-aside designation, indicating open competition. Additionally, AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,254.16 firm-fixed-price delivery order contract is for the supply of XEOMIN 100 unit vials, a specialty pharmaceutical product. The contract has an ultimate completion date of January 10, 2025 and was awarded on December 18, 2024. This award is a part of a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award, valued at $1,179.36, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,738,226 units of XEOMIN 50 unit vials. The contract is a Firm Fixed Price Delivery Order that runs through January 7, 2025. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $2,793.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,093,142 units of XEOMIN 100 UNIT VIALS, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of February 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FDXUH
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,396.85 Firm Fixed Price Delivery Order contract is for the supply of 4567141985 units of XEOMIN 100 UNIT VIALS. The contract has an ultimate completion date of February 25, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This order falls under that IDC. The contract does not have a set-aside designation, indicating open competition.

Generated 5/5/25, 9:50 AM